| Epigenomic blood-based early detection of pancreatic cancer employing cell-free DNA D Haan, A Bergamaschi, V Friedl, GD Guler, Y Ning, R Reggiardo, ... Clinical Gastroenterology and Hepatology 21 (7), 1802-1809. e6, 2023 | 8 | 2023 |
| Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Using Cell-Free DNA 5-Hydroxymethylation Signatures D Haan, A Bergamaschi, GD Guler, V Friedl, Y Ning, R Reggiardo, ... MedRxiv, 2021.12. 27.21268450, 2021 | 2 | 2021 |
| Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non-small cell lung cancer GD Guler, Y Ning, C Coruh, GP Mognol, T Phillips, M Nabiyouni, K Hazen, ... Journal for Immunotherapy of Cancer 12 (1), 2024 | 1 | 2024 |
| 69MO 5-Hydroxymethycytosine analysis reveals stable epigenetic changes in tumor tissue that enable cfDNA cancer predictions F Feng, Y Ning, Y Xue, V Friedl, D Hann, B Gibb, A Bergamaschi, G Guler, ... Annals of Oncology 33, S573, 2022 | 1 | 2022 |
| Abstract A010: Evaluation of the Avantect Pancreatic Cancer Test for identifying high-risk pancreatic cysts A Bergamaschi, D Haan, V Friedl, G Guler, M Kesling, M Collins, K Hazen, ... Cancer Research 84 (2_Supplement), A010-A010, 2024 | | 2024 |
| 7 Anti-PD1 treatment response prediction and monitoring in non-small cell lung cancer patients using plasma cell-free DNA hydroxymethylation G Guler, Y Ning, D Haan, M Kesling, C Coruh, G Mognol, T Phillips, ... J Immunother 10 (2), A1-A1595, 2022 | | 2022 |
| Pancreatic Cancer Detection Using Epigenomic and Genomic Signatures in Plasma-Derived Cell Free DNA in High-Risk Patients With New Onset Diabetes G Guler, A Bergamaschi, D Haan, M Kesling, E McCarthy, T Phillips, ... PANCREAS 50 (7), 1062-1062, 2021 | | 2021 |
| Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers. D Haan, A Bergamaschi, Y Ning, W Gibb, M Kesling, A Pitea, M Nabiyouni, ... Journal of Clinical Oncology 39 (15_suppl), 3044-3044, 2021 | | 2021 |
| Pancreatic cancer detection using EpiDetect signatures in plasma-derived cell free DNA in high-risk patients with new onset diabetes. G Guler, A Bergamaschi, D Haan, M Kesling, Y Ning, C Ellison, W Gibb, ... Journal of Clinical Oncology 39 (15_suppl), e16265-e16265, 2021 | | 2021 |
David HaanUniversity of California Santa CruzVerified email at ucsc.edu
